Pamela Thompson

Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine

Vani Lakshminarayanan, Pamela Thompson, Margreet A. Wolfert et al. · Proceedings of the National Academy of Sciences · 2011 · 300 citations · Full text

Life Sciences, Immunology, Oncology +17

Chemical Modulation of Protein O-GlcNAcylation <i>via</i> OGT Inhibition Promotes Human Neural Cell Differentiation

Lissette M. Andres, Ian W. Blong, Angela C. Evans et al. · ACS Chemical Biology · 2017 · 69 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +17

Immune and Anticancer Responses Elicited by Fully Synthetic Aberrantly Glycosylated MUC1 Tripartite Vaccines Modified by a TLR2 or TLR9 Agonist

Abu‐Baker M. Abdel‐Aal, Vani Lakshminarayanan, Pamela Thompson et al. · ChemBioChem · 2014 · 65 citations

Medicine, Immunology, Oncology +17

Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide

Pamela Thompson, Vani Lakshminarayanan, Nitin T. Supekar et al. · Chemical Communications · 2015 · 61 citations · Full text

Life Sciences, Immunology, Oncology +17

Deciphering Structural Elements of Mucin Glycoprotein Recognition

Andrew J. Borgert, Jamie Heimburg‐Molinaro, Xuezheng Song et al. · ACS Chemical Biology · 2012 · 58 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17